In vitro effects of acetylcholinesterase inhibitors and reactivators on complex I of electron transport chain

Neuroendocrinology Letters

Volumn 32, Issue 3, 2011, Pages 259-263

  Hroudová, Jana ^a   Fišar, Zdeněk ^a   Korábečný, Jan ^b   Kuča, Kamil ^c,d  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^c UNIVERSITY OF DEFENCE   (Czech Republic)

^d UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

7 MEOTA; Acetylcholinesterase; Electron transport chain; NADH dehydrogenase; Oxime; Tacrine

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; 7 METHOXYTACRINE; CHOLINESTERASE INHIBITOR; CHOLINESTERASE REACTIVATOR; OBIDOXIME; PRALIDOXIME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TACRINE; TRIMEDOXIME;

ANIMAL CELL; ARTICLE; BRAIN; CELL ENERGY; ENZYME ACTIVITY; IN VITRO STUDY; MITOCHONDRION; NONHUMAN; RESPIRATORY CHAIN; SPECTROPHOTOMETRY; SWINE;

EID: 80051972307     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Aksenov MY, Tucker HM, Nair P, Aksenova MV, Butterfield DA, Estus S et al. (1999) The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease. Neurochemical Res. 24: 767-774. (Pubitemid 29270460)
2. Antonijevic B, Stojiljkovic MP (2007) Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin Med Res. 5: 71-82. (Pubitemid 350218782)
3. 0-ATPaSe (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging. 23: 371-376.
4. Cardoso SM, Proença MT, Santos S, Santana I, Oliveira CR (2004) Cytochrome c oxidase is decreased in Alzheimer's disease platelets. Neurobiol Aging. 25: 105-110. (Pubitemid 37522198)
5. Chandrasekharan K, Hatanppa K, Brady DR, Rapoport SI (1996) Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease. Exp Neurol. 142: 80-88. (Pubitemid 26381382)
6. Ezoulin MJ, Dong CZ, Liu Z, Li J, Chen HZ, Heymans F et al. (2006) Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment. Toxicol In Vitro. 20: 824-831.
7. Ezoulin MJ, Liu Z, Dutertre-Catella H, Wu G, Dong CZ, Heymans F et al. (2007) A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine. Int Immunopharmacol. 7: 1685-1694.
8. Filip V, Vachek J, Albrecht V, Dvorak I, Dvorakova J, Fusek J et al. (1991) Pharmacokinetics and tolerance of 7-methoxytacrine following the single dose administration in healthy-volunteers. Int J Clin Pharmacol Ther Toxicol. 29: 431-436.
9. Fisar Z (2010) Inhibition of monoamine oxidase activity by cannabinoids. Naunyn-Schmied Arch Pharmacol. 381: 563-572.
10. Fišar Z, Hroudová J, Raboch J (2010) Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers. Neuroendocrinol Lett. 31: 645-656.
11. Folbergrová J, Ješina P, Drahota Z, Lisý V, Haugvicová R, Vojtišková A et al. (2007) Mitochondrial complex I inhibition in cerebral cortex of immature rats following homocysteic acid-induced seizures. Exp Neurol. 204: 597-609. (Pubitemid 46497046)
12. Fukuyama R, Hatanpää K, Rapoport SI, Chandrasekaran K (1996) Gene expression of ND4, a subunit of complex I of oxidative phosphorylation in mitochondria, is decreased in temporal cortex of brains of Alzheimer's disease patients. Brain Res. 713: 290-293. (Pubitemid 26114850)
13. Gibson GE, Sheu KF, Blass JP (1998) Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm. 105: 855-870. (Pubitemid 28539834)
14. Hroudova J, Fisar Z (2010) Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers. Neuroendocrinol Lett. 31: 336-342.
15. Korabecny J, Holas O, Musilek K, Pohanka M, Opletalova V, Dohnal V et al. (2010a) Synthesis and in vitro evaluation of new tacrine derivates-bis-alkylene linked 7-MEOTA. Lett Org Chem. 7: 327-331.
16. Korabecny J, Musilek K, Holas O, Binder J, Zemek F, Marek J et al. (2010b) Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential Cholinesterase inhibitors in Alzheimer disease. Bioorg Med Chem Lett. 20: 6093-6095.
17. Korabecny J, Musilek K, Holas O, Nepovimova E, Jun D, Zemek F et al. (2010c) Synthesis and in vitro evaluation of N-(brombut-3-en-2-yl)-7-methoxy-1, 2,3,4-tetrahydroacridin-9-amine as a Cholinesterase inhibitor with regard to Alzheimer's disease treatment. Molecules. 15: 8804-8812.
18. Kuca K, Jun D, Bajgar J (2007) Currently used Cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro. Drug Chem Toxicol. 30: 31-40.
19. Lorke DE, Nurulain SM, Hasan MY, Kuča K, Musilek K, Petroianu GA (2008) Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from diisopropylfluorophosphate toxicity. J Appl Toxicol. 28: 920-928.
20. Lorke DE, Hasan MY, Nurulain SM, Shafiullah M, Kuča K, Petroianu GA (2011) Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors. J Appl Toxicol. doi: 10.1002/jat.1589.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem. 193: 265-275.
22. Maurer I, Möller H-J (1997) Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. Mol Cell Biochem. 174: 255-259. (Pubitemid 27404200)
23. Maurer I, Zierz S, Möller H-J (2000) A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging. 21: 455-462. (Pubitemid 30349116)
24. Nieoullon A (2010) Acetylcholinesterase inhibitors in Alzheimer's disease: further comments on their mechanisms of action and therapeutic consequences. Psychol Neuropsychiatr Vieil. 8: 123-131.
25. Niklas J, Noor F, Heinzle E (2009) Effects of drugs in subtoxic concentrations on the metabolic fluxes in human hepatoma cell line Hep G2. Toxicol Appl Pharmacol. 240: 327-336.
26. 2 linkers between pyridinium rings and their reactivity against VX. Bioorg Med Chem Lett. 16: 4852-4855. (Pubitemid 44202590)
27. Parker WD, Parks J, Filley CM, Kleinschmidt-DeMasters BK (1994) Electron transport chain defects in Alzheimer's disease brain. Neurology. 44: 1090-1096. (Pubitemid 24188184)
28. Pathak RU, Davey GP (2008) Complex I and energy thresholds in the brain. Biochim Biophys Acta. 1777: 777-782.
29. Prince JA, Yassin MS, Oreland L (1997) Neuroleptic-induced mitochondrial enzyme alterations in the rat brain. J Pharmacol Exp Ther. 280: 261-267. (Pubitemid 27171411)
30. Ragan CI, Wilson MT, Darley-Usmar VM, Lowe PN (1987) Subfractionation of mitochondria and isolation of the proteins of oxidative phosphorylation. In: Darley-Usmar VM, Rickwood D, Wilson MT, editors. Mitochondria. A Practical Approach. London: IRL Press. p. 79-112.
31. Reddy PH, Beal MF (2005) Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Research Reviews. 49: 618-632.
32. Sakurada K, Ikegaya H, Ohta H, Fukushima H, Akutsu T, Watanabe K (2009) Effects of oximes on mitochondrial oxidase activity. Toxicol Lett. 189: 110-114.